|Min SIP Amount||₹500|
|NAV||₹14.69 (22 Jun 2021)|
|Fund Started||02 Mar 2019|
|Fund Size||₹91 Cr|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||8.1%|
|Nestle India Ltd.||FMCG||Equity||7.6%|
|Tata Consultancy Services Ltd.||Technology||Equity||7.4%|
|Hindustan Unilever Ltd.||FMCG||Equity||7.2%|
|Power Grid Corporation of India Ltd.||Energy||Equity||6.8%|
|Britannia Industries Ltd.||FMCG||Equity||4.2%|
|Divi's Laboratories Ltd.||Healthcare||Equity||4.2%|
|Bharti Airtel Ltd.||Communication||Equity||3.1%|
|Asian Paints Ltd.||Chemicals||Equity||2.8%|
SBI Equity Minimum Variance Fund Direct Growth is a Equity Mutual Fund Scheme launched by SBI Mutual Fund. This scheme was made available to investors on 02 Mar 2019. Raviprakash Sharma is the Current Fund Manager of SBI Equity Minimum Variance Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹91 Cr and the Latest NAV as of 22 Jun 2021 is ₹14.69.
The SBI Equity Minimum Variance Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. Exit load of 0.5% if redeemed within 15 days.
The scheme seeks to provide long term capital appreciation by investing in a diversified basket of companies in Nifty 50 Index while aiming for minimizing the portfolio volatility.